US FDA approves Adaptimmune's gene therapy for rare cancer

Adaptimmune Therapeutics

02/08/2024 14:12

Aug 2 (Reuters) - The U.S. Food and Drug Administration
said on Friday it has approved Adaptimmune's  ADAP.O 
first-of-its-kind gene therapy to treat adult patients with a
type of advanced synovial sarcoma who have received prior
chemotherapy.

 (Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi
Majumdar)
 ((Mariam.ESunny@thomsonreuters.com))